Printer Friendly and PDF

Hematology Researchers Elected to IOM

November 1, 2013

On October 21, the National Academy of Sciences announced that J. Evan Sadler, MD, PhD, and colleague Evan D. Kharasch, MD, PhD, had been elected to the Institute of Medicine (IOM). Both men are physician-scientists at Washington University School of Medicine (WUSM) in St. Louis. They are among 70 new members and 10 foreign associates elected to the IOM.

Sadler is professor of medicine and of biochemistry and molecular biophysics. He is also chief of the Division of Hematology at WUSM. As a member of the IOM, Sadler and fellow members will devote a significant amount of volunteer time on committees engaged in a broad range of health-policy issues.

Sadler's scientific work has contributed significantly to an enhanced understanding of blot clotting and bleeding disorders. Sadler's research has resulted in breakthroughs for thrombotic thrombocytopenic purpura, von Willebrand disease and other rare bleeding disorders.

Sadler earned a bachelor's degree from Princeton University, and a doctorate in biochemistry and medical degree from Duke University. After further training and research in hematology at the University of Washington in Seattle, Sadler joined the faculty of WUSM in 1984. He became professor of medicine and of biochemistry and molecular biophysics in 1993. In 2009 he was appointed chief of the Division of Hematology.

Previously Sadler received the Investigator Recognition Awards and a Distinguished Career Award from the International Society on Thrombosis and Haemostasis. He also received the William Dameshek Prize in 1998 from the American Society of Hematology for outstanding contributions to the field. Sadler is a fellow of the American Heart Association and principal investigator of a $9 million grant from the National Heart, Lung, and Blood Institute to support a Translational Research Center in Thrombotic and Hemostatic Disorders.

Established in 1970, the IOM serves as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences and health. It advises the federal government on science and technology issues.


Source: WUSM news release dated October 21, 2013